Oster, Howard, and Moshe Mittelman. 2020. “Rethinking the Effectiveness of Hypomethylating Agents in Myelodysplastic Syndromes: The 50%-2-Year Wall”. Haematologica, September. Pavia, Italy. https://doi.org/10.3324/haematol.2025.300405.